Share Price and Basic Stock Data
Last Updated: November 10, 2025, 4:55 pm
| PEG Ratio | 10.76 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Goldcoin Health Foods Ltd operates in the food processing sector, specifically focusing on bakery, dairy, and fruit products. The company’s market capitalization stood at ₹3.40 Cr, with its share price recorded at ₹11.3. Revenue trends over the years depict a significant decline, with sales reporting only ₹0.04 Cr for the financial year ending March 2023, down from ₹0.07 Cr in March 2022. The trailing twelve months (TTM) revenue slightly improved to ₹0.08 Cr, indicating a marginal recovery. However, quarterly sales data shows minimal fluctuations, remaining at ₹0.01 Cr for several quarters before rising to ₹0.02 Cr in the last two quarters of the forecast period. This stagnation in revenue generation highlights the company’s struggle to enhance its market presence and operational scale in a competitive environment.
Profitability and Efficiency Metrics
Profitability metrics for Goldcoin Health Foods Ltd are concerning, with a reported net profit of -₹0.07 Cr for the most recent financial year. The operating profit margin (OPM) consistently remained negative, with a staggering -350.00% reported for the latest quarter. The company’s return on equity (ROE) stood at 11.1%, while the return on capital employed (ROCE) was notably lower at 8.76%. The interest coverage ratio (ICR) was significantly negative at -28.84x, indicating potential difficulties in meeting interest obligations. This poor profitability and efficiency performance is further compounded by a cash conversion cycle (CCC) of 4,484.29 days, suggesting severe inefficiencies in managing operational liquidity and inventory. The company’s ability to turn sales into actual profit remains a critical challenge.
Balance Sheet Strength and Financial Ratios
Goldcoin Health Foods Ltd’s balance sheet reflects a precarious financial position, with reserves declining to -₹1.98 Cr as of March 2025. The company’s borrowings stood at ₹0.25 Cr, indicating a relatively low level of debt but also a lack of financial cushion. The total assets were recorded at ₹2.19 Cr, while the total liabilities reached ₹2.19 Cr, leading to a debt-to-equity ratio of 0.24x, which is manageable but reflects a lack of leverage for growth. The price-to-book value (P/BV) ratio was noted at 2.69x, suggesting that the stock may be overvalued relative to its net asset value. Financial ratios such as the current ratio at 1.48x indicate a reasonable liquidity position; however, the overall financial stability is undermined by significant losses and negative equity, raising concerns regarding sustainability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Goldcoin Health Foods Ltd reveals a dominant public shareholding of 60.69% and a promoter holding of 39.31%, stable over recent periods. The total number of shareholders increased from 2,181 in December 2022 to 3,249 by March 2025, indicating growing interest among retail investors. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) suggests a lack of confidence from larger investment entities regarding the company’s future prospects. This could stem from the company’s ongoing operational challenges and poor financial performance. The lack of institutional backing may limit the stock’s liquidity and attractiveness to potential investors, emphasizing the need for strategic improvements to regain investor confidence.
Outlook, Risks, and Final Insight
The outlook for Goldcoin Health Foods Ltd remains uncertain, primarily due to its ongoing financial difficulties and operational inefficiencies. The company faces significant risks, including its negative profit margins and a long cash conversion cycle, which may hinder its ability to sustain operations without a strategic turnaround. Additionally, the reliance on a predominantly retail investor base without institutional support could exacerbate volatility in the stock price. On the other hand, potential strengths include its established market presence in the food processing sector and a relatively low debt level, which could provide a foundation for restructuring efforts. If the company can effectively address its operational inefficiencies and enhance revenue generation, it may improve its financial health and restore investor confidence, leading to a more favorable outlook.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Goldcoin Health Foods Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mishtann Foods Ltd | 549 Cr. | 5.09 | 15.9/4.28 | 1.59 | 8.92 | 0.00 % | 42.2 % | 44.1 % | 1.00 |
| Mrs Bectors Food Specialities Ltd | 7,923 Cr. | 1,290 | 1,977/1,201 | 57.1 | 190 | 0.47 % | 18.1 % | 15.6 % | 10.0 |
| Nakoda Group of Industries Ltd | 50.4 Cr. | 29.0 | 48.0/25.2 | 15.7 | 0.00 % | 8.11 % | 15.4 % | 10.0 | |
| HMA Agro Industries Ltd | 1,546 Cr. | 30.8 | 48.3/27.5 | 17.9 | 15.8 | 0.98 % | 11.8 % | 11.5 % | 1.00 |
| Himalaya Food International Ltd | 86.6 Cr. | 10.2 | 20.6/9.29 | 17.0 | 16.4 | 0.00 % | 2.29 % | 2.79 % | 10.0 |
| Industry Average | 21,756.86 Cr | 773.25 | 126.64 | 103.72 | 0.24% | 16.32% | 17.50% | 6.03 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| Expenses | 0.02 | 0.06 | 0.02 | 0.03 | 0.02 | 0.01 | 0.05 | 0.11 | 0.02 | 0.11 | 0.04 | 0.04 | 0.09 |
| Operating Profit | -0.01 | -0.05 | -0.01 | -0.02 | -0.01 | 0.00 | -0.04 | -0.10 | -0.01 | -0.09 | -0.02 | -0.02 | -0.07 |
| OPM % | -100.00% | -500.00% | -100.00% | -200.00% | -100.00% | 0.00% | -400.00% | -1,000.00% | -100.00% | -450.00% | -100.00% | -100.00% | -350.00% |
| Other Income | 0.00 | 0.00 | -0.83 | -0.11 | -0.12 | 0.00 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.12 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | 0.00 |
| Profit before tax | -0.02 | -0.06 | -0.85 | -0.14 | -0.14 | -0.01 | -0.06 | -0.12 | -0.02 | -0.10 | -0.03 | 0.01 | 0.05 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 40.00% |
| Net Profit | -0.01 | -0.05 | -0.84 | -0.13 | -0.13 | -0.01 | -0.06 | -0.12 | -0.02 | -0.09 | -0.03 | 0.01 | 0.04 |
| EPS in Rs | -0.03 | -0.17 | -2.80 | -0.43 | -0.43 | -0.03 | -0.20 | -0.40 | -0.07 | -0.30 | -0.10 | 0.03 | 0.13 |
Last Updated: August 19, 2025, 2:35 pm
Below is a detailed analysis of the quarterly data for Goldcoin Health Foods Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.02 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.02 Cr..
- For Expenses, as of Jun 2025, the value is 0.09 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.04 Cr. (Mar 2025) to 0.09 Cr., marking an increase of 0.05 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.07 Cr.. The value appears to be declining and may need further review. It has decreased from -0.02 Cr. (Mar 2025) to -0.07 Cr., marking a decrease of 0.05 Cr..
- For OPM %, as of Jun 2025, the value is -350.00%. The value appears to be declining and may need further review. It has decreased from -100.00% (Mar 2025) to -350.00%, marking a decrease of 250.00%.
- For Other Income, as of Jun 2025, the value is 0.12 Cr.. The value appears strong and on an upward trend. It has increased from 0.02 Cr. (Mar 2025) to 0.12 Cr., marking an increase of 0.10 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -0.01 Cr. (Mar 2025) to 0.00 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.05 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.05 Cr., marking an increase of 0.04 Cr..
- For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 0.00% (Mar 2025) to 40.00%, marking an increase of 40.00%.
- For Net Profit, as of Jun 2025, the value is 0.04 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Mar 2025) to 0.04 Cr., marking an increase of 0.03 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.13. The value appears strong and on an upward trend. It has increased from 0.03 (Mar 2025) to 0.13, marking an increase of 0.10.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:14 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.96 | 3.22 | 2.54 | 1.74 | 0.94 | 0.69 | 0.36 | 0.16 | 0.07 | 0.04 | 0.04 | 0.07 | 0.08 |
| Expenses | 2.88 | 3.12 | 2.51 | 1.79 | 0.91 | 0.75 | 0.40 | 0.20 | 1.17 | 1.07 | 0.34 | 0.21 | 0.28 |
| Operating Profit | 0.08 | 0.10 | 0.03 | -0.05 | 0.03 | -0.06 | -0.04 | -0.04 | -1.10 | -1.03 | -0.30 | -0.14 | -0.20 |
| OPM % | 2.70% | 3.11% | 1.18% | -2.87% | 3.19% | -8.70% | -11.11% | -25.00% | -1,571.43% | -2,575.00% | -750.00% | -200.00% | -250.00% |
| Other Income | 0.00 | 0.01 | 0.01 | 0.16 | 0.02 | 0.08 | 0.04 | 0.00 | 0.02 | 0.02 | 0.01 | 0.02 | 0.14 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | 0.01 |
| Profit before tax | 0.06 | 0.09 | 0.02 | 0.09 | 0.03 | 0.00 | -0.02 | -0.06 | -1.10 | -1.04 | -0.32 | -0.12 | -0.07 |
| Tax % | 33.33% | 33.33% | 50.00% | 11.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | 0.04 | 0.06 | 0.01 | 0.07 | 0.03 | 0.00 | -0.02 | -0.05 | -1.10 | -1.04 | -0.32 | -0.12 | -0.07 |
| EPS in Rs | 0.13 | 0.20 | 0.03 | 0.23 | 0.10 | 0.00 | -0.07 | -0.17 | -3.67 | -3.47 | -1.07 | -0.40 | -0.24 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 50.00% | -83.33% | 600.00% | -57.14% | -100.00% | -150.00% | -2100.00% | 5.45% | 69.23% | 62.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | -133.33% | 683.33% | -657.14% | -42.86% | -50.00% | -1950.00% | 2105.45% | 63.78% | -6.73% |
Goldcoin Health Foods Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -28% |
| 3 Years: | 0% |
| TTM: | 100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -13% |
| 5 Years: | 16% |
| 3 Years: | 2% |
| 1 Year: | 45% |
| Return on Equity | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -23% |
| 3 Years: | -33% |
| Last Year: | -11% |
Last Updated: September 5, 2025, 3:36 pm
No data available for the Balance Sheet data table.
Cash Flow - No data available for this post.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 50.56 | 73.68 | 104.90 | 157.33 | 326.17 | 518.41 | 1,024.03 | 2,281.25 | 4,275.71 | 7,847.50 | 7,847.50 | 4,484.29 |
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 50.56 | 73.68 | 104.90 | 157.33 | 326.17 | 518.41 | 1,024.03 | 2,281.25 | 4,275.71 | 7,847.50 | 7,847.50 | 4,484.29 |
| Working Capital Days | 49.32 | 68.01 | 102.03 | 151.03 | 287.34 | 460.22 | 1,652.64 | 2,030.31 | 2,190.00 | 5,657.50 | 4,288.75 | -208.57 |
| ROCE % | 2.12% | 2.51% | 0.55% | -0.82% | 0.81% | 0.00% | -0.54% | -1.63% | -33.80% | -43.83% | -18.40% | -8.76% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -0.41 | -1.07 | -3.46 | -3.68 | -0.17 |
| Diluted EPS (Rs.) | -0.41 | -1.07 | -3.46 | -3.68 | -0.17 |
| Cash EPS (Rs.) | -0.40 | -1.00 | -3.39 | -3.61 | -0.10 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 3.39 | 3.80 | 5.02 | 8.48 | 12.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 3.39 | 3.80 | 5.02 | 8.48 | 12.16 |
| Revenue From Operations / Share (Rs.) | 0.21 | 0.11 | 0.13 | 0.23 | 0.52 |
| PBDIT / Share (Rs.) | -0.39 | -0.97 | -3.37 | -3.60 | -0.12 |
| PBIT / Share (Rs.) | -0.39 | -1.04 | -3.44 | -3.67 | -0.18 |
| PBT / Share (Rs.) | -0.40 | -1.06 | -3.46 | -3.68 | -0.18 |
| Net Profit / Share (Rs.) | -0.40 | -1.07 | -3.46 | -3.68 | -0.17 |
| PBDIT Margin (%) | -180.49 | -827.13 | -2474.72 | -1543.69 | -23.32 |
| PBIT Margin (%) | -181.37 | -883.85 | -2523.73 | -1572.32 | -36.07 |
| PBT Margin (%) | -187.63 | -900.96 | -2539.71 | -1577.25 | -36.10 |
| Net Profit Margin (%) | -187.63 | -909.51 | -2539.71 | -1577.25 | -33.45 |
| Return on Networth / Equity (%) | -11.99 | -28.16 | -68.85 | -43.35 | -1.43 |
| Return on Capital Employeed (%) | -9.51 | -22.18 | -55.96 | -39.25 | -1.55 |
| Return On Assets (%) | -5.57 | -17.58 | -49.26 | -37.07 | -1.39 |
| Long Term Debt / Equity (X) | 0.21 | 0.23 | 0.22 | 0.10 | 0.00 |
| Total Debt / Equity (X) | 0.24 | 0.28 | 0.25 | 0.10 | 0.00 |
| Asset Turnover Ratio (%) | 0.03 | 0.01 | 0.01 | 0.02 | 0.04 |
| Current Ratio (X) | 1.48 | 2.12 | 3.34 | 4.94 | 9.09 |
| Quick Ratio (X) | 1.48 | 2.12 | 3.34 | 4.94 | 9.09 |
| Interest Coverage Ratio (X) | -28.84 | -48.33 | -154.86 | -313.01 | -826.37 |
| Interest Coverage Ratio (Post Tax) (X) | -28.98 | -52.14 | -157.92 | -318.81 | -1184.34 |
| Enterprise Value (Cr.) | 2.50 | 2.64 | 2.12 | 2.47 | 1.08 |
| EV / Net Operating Revenue (X) | 38.35 | 74.70 | 51.88 | 35.37 | 6.91 |
| EV / EBITDA (X) | -21.25 | -9.03 | -2.10 | -2.29 | -29.64 |
| MarketCap / Net Operating Revenue (X) | 42.06 | 65.44 | 42.59 | 31.78 | 6.94 |
| Price / BV (X) | 2.69 | 2.03 | 1.15 | 0.87 | 0.29 |
| Price / Net Operating Revenue (X) | 42.22 | 65.81 | 42.65 | 31.80 | 6.94 |
| EarningsYield | -0.04 | -0.13 | -0.59 | -0.49 | -0.04 |
After reviewing the key financial ratios for Goldcoin Health Foods Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has increased from -1.07 (Mar 24) to -0.41, marking an increase of 0.66.
- For Diluted EPS (Rs.), as of Mar 25, the value is -0.41. This value is below the healthy minimum of 5. It has increased from -1.07 (Mar 24) to -0.41, marking an increase of 0.66.
- For Cash EPS (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 3. It has increased from -1.00 (Mar 24) to -0.40, marking an increase of 0.60.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.39. It has decreased from 3.80 (Mar 24) to 3.39, marking a decrease of 0.41.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 3.39. It has decreased from 3.80 (Mar 24) to 3.39, marking a decrease of 0.41.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.21. It has increased from 0.11 (Mar 24) to 0.21, marking an increase of 0.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 2. It has increased from -0.97 (Mar 24) to -0.39, marking an increase of 0.58.
- For PBIT / Share (Rs.), as of Mar 25, the value is -0.39. This value is below the healthy minimum of 0. It has increased from -1.04 (Mar 24) to -0.39, marking an increase of 0.65.
- For PBT / Share (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 0. It has increased from -1.06 (Mar 24) to -0.40, marking an increase of 0.66.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -0.40. This value is below the healthy minimum of 2. It has increased from -1.07 (Mar 24) to -0.40, marking an increase of 0.67.
- For PBDIT Margin (%), as of Mar 25, the value is -180.49. This value is below the healthy minimum of 10. It has increased from -827.13 (Mar 24) to -180.49, marking an increase of 646.64.
- For PBIT Margin (%), as of Mar 25, the value is -181.37. This value is below the healthy minimum of 10. It has increased from -883.85 (Mar 24) to -181.37, marking an increase of 702.48.
- For PBT Margin (%), as of Mar 25, the value is -187.63. This value is below the healthy minimum of 10. It has increased from -900.96 (Mar 24) to -187.63, marking an increase of 713.33.
- For Net Profit Margin (%), as of Mar 25, the value is -187.63. This value is below the healthy minimum of 5. It has increased from -909.51 (Mar 24) to -187.63, marking an increase of 721.88.
- For Return on Networth / Equity (%), as of Mar 25, the value is -11.99. This value is below the healthy minimum of 15. It has increased from -28.16 (Mar 24) to -11.99, marking an increase of 16.17.
- For Return on Capital Employeed (%), as of Mar 25, the value is -9.51. This value is below the healthy minimum of 10. It has increased from -22.18 (Mar 24) to -9.51, marking an increase of 12.67.
- For Return On Assets (%), as of Mar 25, the value is -5.57. This value is below the healthy minimum of 5. It has increased from -17.58 (Mar 24) to -5.57, marking an increase of 12.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.21, marking a decrease of 0.02.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has decreased from 0.28 (Mar 24) to 0.24, marking a decrease of 0.04.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.03. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 1.48. This value is below the healthy minimum of 1.5. It has decreased from 2.12 (Mar 24) to 1.48, marking a decrease of 0.64.
- For Quick Ratio (X), as of Mar 25, the value is 1.48. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.48, marking a decrease of 0.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -28.84. This value is below the healthy minimum of 3. It has increased from -48.33 (Mar 24) to -28.84, marking an increase of 19.49.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -28.98. This value is below the healthy minimum of 3. It has increased from -52.14 (Mar 24) to -28.98, marking an increase of 23.16.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2.50. It has decreased from 2.64 (Mar 24) to 2.50, marking a decrease of 0.14.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 38.35. This value exceeds the healthy maximum of 3. It has decreased from 74.70 (Mar 24) to 38.35, marking a decrease of 36.35.
- For EV / EBITDA (X), as of Mar 25, the value is -21.25. This value is below the healthy minimum of 5. It has decreased from -9.03 (Mar 24) to -21.25, marking a decrease of 12.22.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 42.06. This value exceeds the healthy maximum of 3. It has decreased from 65.44 (Mar 24) to 42.06, marking a decrease of 23.38.
- For Price / BV (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has increased from 2.03 (Mar 24) to 2.69, marking an increase of 0.66.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 42.22. This value exceeds the healthy maximum of 3. It has decreased from 65.81 (Mar 24) to 42.22, marking a decrease of 23.59.
- For EarningsYield, as of Mar 25, the value is -0.04. This value is below the healthy minimum of 5. It has increased from -0.13 (Mar 24) to -0.04, marking an increase of 0.09.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Goldcoin Health Foods Ltd:
- Net Profit Margin: -187.63%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -9.51% (Industry Average ROCE: 16.32%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -11.99% (Industry Average ROE: 17.5%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -28.98
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.48
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 373 (Industry average Stock P/E: 126.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.24
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -187.63%